Food allergy deserves precise characterization — not just avoidance.
IgE-mediated food allergy is part of the broader atopic spectrum. Modern care moves beyond strict avoidance to structured risk stratification and disease-modifying options.
Living with food allergy
Beyond the reactions themselves, food allergy carries persistent anxiety around social eating, travel and parenting. Precise characterization replaces uncertainty with a clear, individualized plan.
When to seek specialized evaluation
- Prior reaction with hives, swelling, breathing or GI symptoms after eating
- Any prior epinephrine use
- Multiple suspected foods or unclear culprit
- Coexisting asthma, atopic dermatitis or eosinophilic esophagitis
- Interest in oral immunotherapy or biologic options
How we evaluate
We reconstruct each reaction in detail, review prior specific IgE / skin testing and component diagnostics when available, stratify anaphylaxis risk, and structure an individualized action plan with epinephrine training and avoidance strategy.
Advanced treatment options
Modern care includes oral immunotherapy for selected foods and — for IgE-mediated food allergy at risk of severe accidental reactions — biologic therapy with anti-IgE (omalizumab, FDA-approved 2024) to reduce reaction severity. We orient on candidacy within current evidence.
Food allergy within the atopic spectrum.
Food allergy frequently coexists with eczema, asthma and eosinophilic esophagitis driven by shared type 2 biology. A unified evaluation often reframes the long-term plan.
